Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Levi-Schaffer

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Immunology|February 6, 2020
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacologySimon D Harding, Elena Faccenda, Christopher Southan, et al.
Scandinavian Journal of Immunology|February 24, 2021
Physiology and pathology of eosinophils: Recent developments: Summary of the Focus Workshop Organized by DGAKIHarald Renz, Claus Bachert, Claudia Berek, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2022
Patients with coronavirus disease 2019 characterized by dysregulated levels of membrane and soluble cluster of differentiation 48Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, et al.
Nature Communications|October 21, 2025
Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasisIlan Zaffran, Pratibha Gaur, Prince Ofori, et al.
British Journal of Pharmacology|May 3, 2020
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29Steve P H Alexander, Jane F Armstrong, Anthony P Davenport, et al.
Nature Communications|May 5, 2022
Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGITYoav Charpak-Amikam, Tom Lapidus, Batya Isaacson, et al.
Frontiers in Immunology|August 10, 2019
Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel DiseaseCindy Barnig, Tjitske Bezema, Philip C Calder, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 20, 2023
For allergists, the solution is never violence!Jonathan Spergel, Larry Borish, Mitchell H Grayson, et al.
European Journal of Immunology|December 16, 2024
KIRA6 is an Effective and Versatile Mast Cell Inhibitor of IgE-mediated ActivationVeronika Wunderle, Thomas Wilhelm, Shatha Boukeileh, et al.
Eclinicalmedicine|June 11, 2025
European advances in digital rheumatology: explainable insights and personalized digital health tools for psoriatic arthritisLeontios J Hadjileontiadis, Vasileios Charisis, Stelios Hadjidimitriou, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Immunology|February 6, 2020
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacologySimon D Harding, Elena Faccenda, Christopher Southan, et al.
Scandinavian Journal of Immunology|February 24, 2021
Physiology and pathology of eosinophils: Recent developments: Summary of the Focus Workshop Organized by DGAKIHarald Renz, Claus Bachert, Claudia Berek, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2022
Patients with coronavirus disease 2019 characterized by dysregulated levels of membrane and soluble cluster of differentiation 48Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, et al.
Nature Communications|October 21, 2025
Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasisIlan Zaffran, Pratibha Gaur, Prince Ofori, et al.
British Journal of Pharmacology|May 3, 2020
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29Steve P H Alexander, Jane F Armstrong, Anthony P Davenport, et al.
Nature Communications|May 5, 2022
Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGITYoav Charpak-Amikam, Tom Lapidus, Batya Isaacson, et al.
Frontiers in Immunology|August 10, 2019
Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel DiseaseCindy Barnig, Tjitske Bezema, Philip C Calder, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 20, 2023
For allergists, the solution is never violence!Jonathan Spergel, Larry Borish, Mitchell H Grayson, et al.
European Journal of Immunology|December 16, 2024
KIRA6 is an Effective and Versatile Mast Cell Inhibitor of IgE-mediated ActivationVeronika Wunderle, Thomas Wilhelm, Shatha Boukeileh, et al.
Eclinicalmedicine|June 11, 2025
European advances in digital rheumatology: explainable insights and personalized digital health tools for psoriatic arthritisLeontios J Hadjileontiadis, Vasileios Charisis, Stelios Hadjidimitriou, et al.
Pageof 18